United States Proton Therapy Market, Patients by 14 Cancer Types, Reimbursement Policies & Persons Treated at Centers

  • ID: 4496236
  • Report
  • Region: United States
  • 147 Pages
  • Renub Research
1 of 5
The United States Proton Therapy Market has Potential to Surpass US$ 16 Billion by the End of 2024

FEATURED COMPANIES

  • Elekta
  • IBA
  • Varian Medical Systems
  • MORE

'United States Proton Therapy Market, Patients by 14 Cancer Types (Central Nervous System Tumors, Intraocular Melanomas Cancer, Pituitary Neoplasms Cancer, Base of Skull / Axial Skeleton Cancer, Head and Neck Cancer, Lung Cancer, Retroperitoneal Sarcoma Cancer, Pediatric Cancer Cases (Up to Age 18), Gastrointestinal Tract Cancer, Urinary Tract Cancer, Female Pelvic Organs Cancer, Prostate Cancer, Breast Cancer & Other Cancer) Reimbursement Policies & Persons Treated at Centers'

United States proton therapy market has potential to surpass US$ 16 Billion by the end of 2024. In current outlook, the United States captures more than 40 percent of Proton Beam Therapy Facility worldwide. The growth of proton therapy center in the United States is substantial and the number of new advanced proton therapy center would be launched in forecast time-frame. In the United States, almost 14 centers are in development phase (either under-construction or planning phase) will further boost the market of proton therapy.

By 14 Cancer Types - United States Proton Therapy Market & Patients:

In this report, we have done comprehensive analysis of proton therapy market and proton therapy patient numbers by 14 cancer/tumor types to understand which cancer type has more or less inclination towards proton therapy technology. In proton therapy, the frequency of patients is much higher in prostate cancer followed by pediatric cancer because of its compatibility and survival rate. The report covers 14 cancer types as follows: Central Nervous System Tumors, Lung Cancer, Pituitary Neoplasms Cancer, Pediatric Cancer Cases (Up to Age 18), Base of Skull / Axial Skeleton Cancer, Urinary Tract Cancer, Head and Neck Cancer, Gastrointestinal Tract Cancer, Intraocular Melanomas Cancer, Retroperitoneal Sarcoma Cancer, Breast Cancer, Female Pelvic Organs Cancer, Prostate Cancer & Other Cancer.

Annually Treated Patient Database by Proton Therapy Center in United States:

In this report, we have covered the number of proton therapy patients treated by each proton therapy center since their inception and till 2017 on annual basis. According to the research findings, proton therapy center in United States efficiently manage the patients. Moreover, they are also expanding their capacity, improving technical skills and changing minor technology for the treatment of more people simultaneously.

United States Reimbursement Policy regarding Proton Beam Therapy:

In this report, we have done complete assessment on the United States proton therapy reimbursement policies. We have divided the reimbursement policy into two sections; by patients and by manufacturer, stakeholder and institutions.

In this report, the researchers have studied the market in two parts a) Actual Market and b) Potential Market. The report also talks about a list of all operational and future Proton Therapy centers; Economics of proton therapy including reimbursement policies. Proton Therapy revenues from 3 companies (IBA, Varian Medical Systems, Elekta) has also been studied in the report.

a) Actual Market is the current market which is already present

b) Potential Market is the market which can be achieved; but it has yet not been achieved due to demand and supply gap. At present only a few proton therapy centers are available that can treat a limited number of patients each year.

United States Proton Therapy Market has been analyzed from 6 View Points (2009 - 2024):

  • Actual Market & Forecast
  • Potential Market & Forecast
  • By 14 Cancer Types - USA Proton Therapy Market
  • Patient Numbers & Forecast
  • Potential Patient Numbers & Forecast
  • By 14 Cancer Types- USA Proton Therapy Patient Numbers

Cancer Types - Proton Therapy Market & Patient Numbers:

1. Central Nervous System Tumors
2. Intraocular Melanomas Cancer
3. Pituitary Neoplasms Cancer
4. Base of Skull / Axial Skeleton Cancer
5. Head and Neck Cancer
6. Lung Cancer
7. Retroperitoneal Sarcoma Cancer
8. Pediatric Cancer Cases (Up to Age 18)
9. Gastrointestinal Tract Cancer
10. Urinary Tract Cancer
11. By Female Pelvic Organs Cancer
12. Prostate Cancer
13. Breast Cancer
14. Other Cancer

Key Companies Covered:

1. IBA (Overview, Sales Analysis)
2. Varian Medical Systems (Overview, Sales Analysis)
3. Elekta (Overview, Sales Analysis)

READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Elekta
  • IBA
  • Varian Medical Systems
  • MORE

1. Executive Summary

2. Market (Actual & Potential) - United States Proton Therapy Market (2009 - 2024)
2.1 Actual Proton Therapy Market
2.2 Potential Proton Therapy Market

3. Number of Patients - United States Proton Therapy (2009 - 2024)
3.1 Actual Numbers
3.2 Potential Numbers

4. Cancer Types - Patients Number in United States Proton Therapy (2009 - 2024)
4.1 Central Nervous System Tumors
4.2 Intraocular Melanomas Cancer
4.3 Pituitary Neoplasms Cancer
4.4 Base of Skull / Axial Skeleton Cancer
4.5 Head and Neck Cancer
4.6 Lung Cancer
4.7 Retroperitoneal Sarcoma Cancer
4.8 Pediatric Cancer Cases (Up to Age 18)
4.9 Gastrointestinal Tract Cancer
4.10 Urinary Tract Cancer
4.11 By Female Pelvic Organs Cancer
4.12 Prostate Cancer
4.13 Breast Cancer
4.14 Other Cancer

5. Cancer Types - United States Proton Therapy Market (2009 - 2024)
5.1 Central Nervous System Tumors
5.2 Intraocular Melanomas Cancer
5.3 Pituitary Neoplasms Cancer
5.4 Base of Skull / Axial Skeleton Cancer
5.5 Head and Neck Cancer
5.6 Lung Cancer
5.7 Retroperitoneal Sarcoma Cancer
5.8 Pediatric Cancer (Up to Age 18)
5.9 Gastrointestinal Tract Cancer
5.10 Urinary Tract Cancer
5.11 Female Pelvic Organs Cancer
5.12 Prostate Cancer
5.13 Breast Cancer
5.14 Other Cancer

6. United States - List of Proton Therapy Centers
6.1 Operating Proton Therapy Centers
6.2 Under-Construction Therapy Centers
6.3 Planning Proton Therapy Centers

7. By Centers - Number of Proton Therapy Patients Treated
7.1 Loma Linda (LLUMC) Proton Therapy Center (2008 - 2016)
7.2 UCSF - CNL Proton Therapy Center (2008 - 2015)
7.3 Boston (NPTC) Proton Therapy Center (2008 - 2016)
7.4 Bloomington (MPRI, 2) Proton Therapy Center (2008 - 2014)
7.5 Houston (MD Anderson) Proton Therapy Center (2008 - 2016)
7.6 UFPTI Jacksonville Proton Therapy Center (2008 - 2016)
7.7 Oklahoma City (ProCure PTC) Proton Therapy Center (2009 - 2017)
7.8 CDH Warrenville Proton Therapy Center (2010 - 2016)
7.9 Philadelphia (Upenn) Proton Therapy Center (2011 - 2016)
7.10 Hampton (HUPTI) Proton Therapy Center (2012 - 2016)
7.11 New Jersey (ProCure PTC) Proton Therapy Center (2012 - 2016)
7.12 Seattle (SCCA ProCure PTC) Proton Therapy Center (2013 - 2016)
7.13 St. Louis (S. Lee King PTC) Proton Therapy Center (2013 - 2016)
7.14 Provision Center for Proton Therapy, Knoxville, TN (2014 - 2016)
7.15 San Diego (Scripps PTC) (2014 - 2017)
7.16 Shreveport (Willis Knighton) Proton Therapy Center (2014 - 2017)
7.17 Jacksonville (Ackerman CC) Proton Therapy Center (2015 - 2016)
7.18 Rochester (Mayo PBTC) Proton Therapy Center (2015 - 2016)
7.19 Brunswick (Laurie PC) Proton Therapy Center (2015)
7.20 Irving (Texas Center for PT) Proton Therapy Center (2015 - 2017)
7.21 Memphis (St. Jude PTC) Proton Therapy Center (2015 - 2017)
7.22 Phoenix (Mayo PBTC) Proton Therapy Center (2016)
7.23 Baltimore (Maryland PTC) Proton Therapy Center (2016)
7.24 Cincinnati (Children's PTC) Proton Therapy Center (2016)
7.25 Orlando (Orlando Health PTC) Proton Therapy Center (2016)
7.26 Cleveland (UH Sideman PTC) Proton Therapy Center (2016)

8. Proton Therapy - Reimbursement Policies
8.1 Proton Therapy Reimbursement Policies for Patients
8.2 Proton Therapy Reimbursement for Institutions, Stakeholders and Manufacturers

9. Components of a Standard Proton Therapy Center
9.1 Proton Accelerator
9.1.1 Synchrotrons (example: LLUMC at Loma Linda)
9.1.2 Cyclotrons (example: MGH Boston)
9.1.3 Synchrocyclotrons (examples: Orsay, Uppsala)
9.1.4 Linacs (Rome)
9.1.5 H-minus Synchrotrons
9.1.6 Separated Sector Cyclotrons
9.1.7 Super-conducting Cyclotrons
9.1.8 Fast Cycling Synchrotron
9.2 Beam Transport System
9.3 Beam Delivery System
9.3.1 The Passive Scattering Technique
9.3.2 Beam Scanning
9.4 Nozzle
9.4.1 Single Scattering
9.4.2 Double Scattering
9.4.3 Uniform Scanning Nozzle
9.4.4 Pencil Scanning Nozzle
9.5 Treatment Planning System
9.6 Image Viewers
9.7 Patient Positioning System (PPS)
9.8 Human Resource

10. Company Analysis (2010 - 2021)
10.1 IBA Proton Therapy
10.1.1 Sales Analysis

10.2 Varian Medical Systems
10.2.1 Sales Analysis

10.3 Elekta
10.3.1 Sales Analysis

11. Driving Factors for Proton Therapy
11.1 Point No. 1
11.2 Point No. 2

12. Challenges in Proton Therapy
12.1 Point no. 1
12.2 Point No. 2

List of Figures
Figure 2-1: United States - Proton Therapy Market (Million US$), 2009 - 2017
Figure 2-2: United States - Forecast for Proton Therapy Market (Million US$), 2018 - 2024
Figure 2-3: United States - Potential Proton Therapy Market (Million US$), 2009 - 2017
Figure 2-4: United States - Forecast for Potential Proton Therapy Market (Million US$), 2018 - 2024
Figure 3-1: United States - Patient Treated with Proton Therapy (Number), 2009 - 2017
Figure 3-2: United States - Forecast for Patient Treated with Proton Therapy (Number), 2018 - 2024
Figure 3-3: United States - Potential Candidate for Proton Therapy (Number), 2009 - 2017
Figure 3-4: United States - Forecast for Potential Candidate for Proton Therapy (Number), 2018 - 2024
Figure 4-1: United States - Proton Therapy Patient by Central Nervous System Tumors (Number), 2009 - 2017
Figure 4-2: United States - Forecast for Proton Therapy Patient by Central Nervous System Tumors (Number), 2018 - 2024
Figure 4-3: United States - Proton Therapy Patient by Intraocular Melanomas Cancer (Number), 2009 - 2017
Figure 4-4: United States - Forecast for Proton Therapy Patient by Intraocular Melanomas Cancer (Number), 2018 - 2024
Figure 4-5: United States - Proton Therapy Patient by Pituitary Neoplasms Cancer (Number), 2009 - 2017
Figure 4-6: United States - Forecast for Proton Therapy Patient by Pituitary Neoplasms Cancer (Number), 2018 - 2024
Figure 4-7: United States - Proton Therapy Patient by Base of Skull / Axial Skeleton Cancer (Number), 2009 - 2017
Figure 4-8: United States - Forecast for Proton Therapy Patient by Base of Skull / Axial Skeleton Cancer (Number), 2018 - 2024
Figure 4-9: United States - Proton Therapy Patient by Head and Neck Cancer (Number), 2009 - 2017
Figure 4-10: United States - Forecast for Proton Therapy Patient by Head and Neck Cancer (Number), 2018 - 2024
Figure 4-11: United States - Proton Therapy Patient by Lung Cancer (Number), 2009 - 2017
Figure 4-12: United States - Forecast for Proton Therapy Patient by Lung Cancer (Number), 2018 - 2024
Figure 4-13: United States - Proton Therapy Patient by Retroperitoneal Sarcoma Cancer (Number), 2009 - 2017
Figure 4-14: United States - Forecast for Proton Therapy Patient by Retroperitoneal Sarcoma Cancer (Number), 2018 - 2024
Figure 4-15: United States - Proton Therapy Patient by Pediatric Cancer (Number), 2009 - 2017
Figure 4-16: United States - Forecast for Proton Therapy Patient by Pediatric Cancer (Number), 2018 - 2024
Figure 4-17: United States - Proton Therapy Patient by Gastrointestinal Tract Cancer (Number), 2009 - 2017
Figure 4-18: United States - Forecast for Proton Therapy Patient by Gastrointestinal Tract Cancer (Number), 2018 - 2024
Figure 4-19: United States - Proton Therapy Patient by Urinary Tract Cancer (Number), 2009 - 2017
Figure 4-20: United States - Forecast for Proton Therapy Patient by Urinary Tract Cancer (Number), 2018 - 2024
Figure 4-21: United States - Proton Therapy Patient by Female Pelvic Organs Cancer (Number), 2009 - 2017
Figure 4-22: United States - Forecast for Proton Therapy Patient by Female Pelvic Organs Cancer (Number), 2018 - 2024
Figure 4-23: United States - Proton Therapy Patient by Prostate Cancer (Number), 2009 - 2017
Figure 4-24: United States - Forecast for Proton Therapy Patient by Prostate Cancer (Number), 2018 - 2024
Figure 4-25: United States - Proton Therapy Patient by Breast Cancer (Number), 2009 - 2017
Figure 4-26: United States - Forecast for Proton Therapy Patient by Breast Cancer (Number), 2018 - 2024
Figure 4-27: United States - Proton Therapy Patient by Other Cancer (Number), 2009 - 2017
Figure 4-28: United States - Forecast for Proton Therapy Patient by Other Cancer (Number), 2018 - 2024
Figure 5-1: United States - Proton Therapy Market by Central Nervous System Tumors (Million US$), 2009 - 2017
Figure 5-2: United States - Forecast for Proton Therapy Market by Central Nervous System Tumors (Million US$), 2018 - 2024
Figure 5-3: United States - Proton Therapy Market by Intraocular Melanomas Cancer (Million US$), 2009 - 2017
Figure 5-4: United States - Forecast for Proton Therapy Market by Intraocular Melanomas Cancer (Million US$), 2018 - 2024
Figure 5-5: United States - Proton Therapy Market by Pituitary Neoplasms Cancer (Million US$), 2009 - 2017
Figure 5-6: United States - Forecast for Proton Therapy Market by Pituitary Neoplasms Cancer (Million US$), 2018 - 2024
Figure 5-7: United States - Proton Therapy Market by Base of Skull / Axial Skeleton Cancer (Million US$), 2009 - 2017
Figure 5-8: United States - Forecast for Proton Therapy Market by Base of Skull / Axial Skeleton Cancer (Million US$), 2018 - 2024
Figure 5-9: United States - Proton Therapy Market by Head and Neck Cancer (Million US$), 2009 - 2017
Figure 5-10: United States - Forecast for Proton Therapy Market by Head and Neck Cancer (Million US$), 2018 - 2024
Figure 5-11: United States - Proton Therapy Market by Lung Cancer (Million US$), 2009 - 2017
Figure 5-12: United States - Forecast for Proton Therapy Market by Lung Cancer (Million US$), 2018 - 2024
Figure 5-13: United States - Proton Therapy Market by Retroperitoneal Sarcoma Cancer (Million US$), 2009 - 2017
Figure 5-14: United States - Forecast for Proton Therapy Market by Retroperitoneal Sarcoma Cancer (Million US$), 2018 - 2024
Figure 5-15: United States - Proton Therapy Market by Pediatric Cancer (Million US$), 2009 - 2017
Figure 5-16: United States - Forecast for Proton Therapy Market by Pediatric Cancer (Million US$), 2018 - 2024
Figure 5-17: United States - Proton Therapy Market by Gastrointestinal Tract Cancer (Million US$), 2009 - 2017
Figure 5-18: United States - Forecast for Proton Therapy Market by Gastrointestinal Tract Cancer (Million US$), 2018 - 2024
Figure 5-19: United States - Proton Therapy Market by Urinary Tract Cancer (Million US$), 2009 - 2017
Figure 5-20: United States - Forecast for Proton Therapy Market by Urinary Tract Cancer (Million US$), 2018 - 2024
Figure 5-21: United States - Proton Therapy Market by Female Pelvic Organs Cancer (Million US$), 2009 - 2017
Figure 5-22: United States - Forecast for Proton Therapy Market by Female Pelvic Organs Cancer (Million US$), 2018 - 2024
Figure 5-23: United States - Proton Therapy Market by Prostate Cancer (Million US$), 2009 - 2017
Figure 5-24: United States - Forecast for Proton Therapy Market by Prostate Cancer (Million US$), 2018 - 2024
Figure 5-25: United States - Proton Therapy Market by Breast Cancer (Million US$), 2009 - 2017
Figure 5-26: United States - Forecast for Proton Therapy Market by Breast Cancer (Million US$), 2018 - 2024
Figure 5-27: United States - Proton Therapy Market by Other Cancer (Million US$), 2009 - 2017
Figure 5-28: United States - Forecast for Proton Therapy Market by Other Cancer (Million US$), 2018 - 2024
Figure 10-1: Global - IBA Proton Therapy Sales (Million US$), 2010 - 2017
Figure 10-2: Global - Forecast for IBA Proton Therapy Sales (Million US$), 2018 - 2024
Figure 10-3: Global - Varian Medical Systems Oncology Systems Sales (Million US$), 2010 - 2017
Figure 10-4: Global - Forecast for Varian Medical Systems Oncology Systems Sales (Million US$), 2018 - 2024
Figure 10-5: Global - Elekta Radiation Technology Sales (Million US$), 2010 - 2017
Figure 10-6: Global - Forecast for Elekta Radiation Technology Sales (Million US$), 2018 - 2024
Figure 11-1: United States - Number of Patient Diagnosed With Cancer (Thousand), 2009 - 2017
Figure 11-2: United States - Forecast for Number of Patient Diagnosed With Cancer (Thousand), 2018 - 2024

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Elekta
  • IBA
  • Varian Medical Systems
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll